159 related articles for article (PubMed ID: 36734734)
1. Myasthenia gravis as an unusual non-hematological autoimmune manifestation of a relapsed chronic lymphocytic leukemia - clinical case and review of literature.
Dimitrova S; Efraim M; Micheva I
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(2):649-652. PubMed ID: 36734734
[TBL] [Abstract][Full Text] [Related]
2. Obinutuzumab Plus Chlorambucil in a Patient with Severe Myasthenia Gravis and Chronic Lymphocytic Leukemia.
Russell A; Yaraskavitch M; Fok D; Chhibber S; Street L; Korngut L
J Neuromuscul Dis; 2017; 4(3):251-257. PubMed ID: 28869483
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
[TBL] [Abstract][Full Text] [Related]
4. Detection of red cell alloantibody prior to overflow phenomenon in a case of warm AIHA secondary to Chronic Lymphocytic Leukemia and Myasthenia Gravis: A case report.
Bava D; Asirvatham V; Mandal S; Rohila AK; Mittal S
Transfus Clin Biol; 2023 Nov; 30(4):449-453. PubMed ID: 37689387
[TBL] [Abstract][Full Text] [Related]
5. Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates.
Ingelfinger F; Kramer M; Lutz M; Widmer CC; Piccoli L; Kreutmair S; Wertheimer T; Woodhall M; Waters P; Sallusto F; Lanzavecchia A; Mundt S; Becher B; Schreiner B
Neurol Neuroimmunol Neuroinflamm; 2023 Mar; 10(2):. PubMed ID: 36754834
[TBL] [Abstract][Full Text] [Related]
6. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
7. Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia.
Jung M; Rice L
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S10-3. PubMed ID: 22035737
[TBL] [Abstract][Full Text] [Related]
8. [Myasthenia gravis and chronic lymphocytic leukemia: a lucky association?].
Rey J; Attarian S; Disdier P; Feuillet L; Azulay JP; Pouget J
Rev Med Interne; 2001 Nov; 22(11):1129-30. PubMed ID: 11817127
[No Abstract] [Full Text] [Related]
9. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma.
Gajra A; Vajpayee N; Grethlein SJ
Am J Hematol; 2004 Oct; 77(2):196-7. PubMed ID: 15389902
[TBL] [Abstract][Full Text] [Related]
10. Chiari type I malformation: a mimicker of myasthenia gravis.
Muthusamy P; Matte G; Kosmorsky G; Chémali KR
Neurologist; 2011 Mar; 17(2):86-8. PubMed ID: 21364360
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis and chronic lymphocytic leukaemia.
Bennett M; Berrebi A; Katz A
Eur J Haematol; 1989 Jan; 42(1):104. PubMed ID: 2914588
[No Abstract] [Full Text] [Related]
12. [Myasthenia gravis and its association with lymphoproliferative disorders: a case series].
Cea G; Gallardo V A; Cabrera C ME
Rev Med Chil; 2017 Dec; 145(12):1626-1630. PubMed ID: 29652962
[TBL] [Abstract][Full Text] [Related]
13. [Myasthenia gravis--current treatment standards and emerging drugs].
Markéta K; Kamil M; Kamil K
Ceska Slov Farm; 2011 Apr; 60(2):47-53. PubMed ID: 21650005
[TBL] [Abstract][Full Text] [Related]
14. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
Mutluay R; Aki SZ; Erten Y; Konca C; Yagci M; Barit G; Sindel S
Clin Nephrol; 2008 Dec; 70(6):527-31. PubMed ID: 19049712
[TBL] [Abstract][Full Text] [Related]
15. Decompensating esophoria as the presenting feature of myasthenia gravis.
Arblaster GE; Shipman TL; Pepper IM
J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293
[TBL] [Abstract][Full Text] [Related]
16. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in chronic lymphocytic leukemia.
Jaglowski SM; Byrd JC
Semin Hematol; 2010 Apr; 47(2):156-69. PubMed ID: 20350663
[TBL] [Abstract][Full Text] [Related]
18. [ORL manifestations of myasthenia gravis].
Bravo Domínguez O; Foglia Fernández M; González Compte X; Jiménez Montoya R; Girons Bonells J; Dicenta Sousa M
Acta Otorrinolaringol Esp; 2000; 51(6):549-51. PubMed ID: 11142795
[TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.
Osterborg A; Karlsson C; Lundin J
Curr Hematol Malig Rep; 2009 Jan; 4(1):47-53. PubMed ID: 20425438
[TBL] [Abstract][Full Text] [Related]
20. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
